Expected Earnings Per Share (EPS): -$0.56, indicating anticipated losses.
Revenue Projection: Approximately $6.93 million, reflecting the company’s financial challenges.
Financial Ratios: Negative price-to-earnings (P/E) ratio of -3.80 and a price-to-sales ratio of 1.94, highlighting investor concerns and valuation metrics.
ElectroCore, Inc. (NASDAQ:ECOR) is a commercial-stage bioelectronic technology company. It focuses on developing non-invasive therapies for various health conditions. As a player in the bioelectronic medicine field, ECOR competes with other companies that are exploring similar non-invasive treatment options. The company is set to release its quarterly earnings on May 7, 2025.
Wall Street estimates ECOR’s earnings per share (EPS) to be -$0.56, indicating expected losses. The revenue projection stands at approximately $6.93 million. This aligns with the company’s current financial challenges, as highlighted by its negative price-to-earnings (P/E) ratio of -3.80. This ratio shows that ECOR is experiencing negative earnings, which is a concern for investors.
The price-to-sales ratio of 1.94 suggests that investors are willing to pay $1.94 for every dollar of sales. This is slightly lower than the enterprise value to sales ratio of 1.97, which includes the company’s debt in its valuation. The enterprise value to operating cash flow ratio is -7.13, indicating difficulties in generating positive cash flow from operations.
ECOR’s earnings yield is negative at -26.32%, further emphasizing its financial struggles. However, the company maintains a moderate debt-to-equity ratio of 0.55, showing a balanced approach to leveraging debt. The current ratio of 1.78 suggests that ECOR has a healthy liquidity position, capable of covering its short-term liabilities.
Following the earnings release, ECOR’s management will host a webinar to discuss the financial results and future prospects. This event offers stakeholders a chance to gain insights into the company’s performance and strategies. For more information about ECOR and its technologies, visit their website.
